Media stories about Landauer (NYSE:LDR) have been trending positive recently, according to Accern. The research firm identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Landauer earned a news impact score of 0.25 on Accern’s scale. Accern also assigned news headlines about the scientific and technical instruments company an impact score of 45.8561828071621 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Shares of Landauer (NYSE:LDR) traded down $0.05 during mid-day trading on Tuesday, hitting $67.20. 705,800 shares of the stock were exchanged, compared to its average volume of 56,169. The company has a debt-to-equity ratio of 3.26, a quick ratio of 1.87 and a current ratio of 2.02. Landauer has a twelve month low of $41.00 and a twelve month high of $68.50.

A number of research analysts have weighed in on LDR shares. Hilliard Lyons raised shares of Landauer from an “underperform” rating to a “neutral” rating in a research note on Wednesday, September 6th. Zacks Investment Research lowered shares of Landauer from a “buy” rating to a “hold” rating in a research note on Thursday, September 7th. Finally, BidaskClub lowered shares of Landauer from a “sell” rating to a “strong sell” rating in a research note on Tuesday, August 1st.

TRADEMARK VIOLATION WARNING: “Landauer (LDR) Receiving Favorable News Coverage, Analysis Shows” was originally reported by Watch List News and is owned by of Watch List News. If you are reading this piece on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright law. The correct version of this piece can be viewed at

About Landauer

Landauer, Inc is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a provider of outsourced medical physics services, and a provider of radiology related medical products. The Company operates through three segments: Radiation Measurement, Medical Physics and Medical Products.

Insider Buying and Selling by Quarter for Landauer (NYSE:LDR)

Receive News & Ratings for Landauer Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Landauer Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.